List of Redx Pharma PLC patents

List of Redx Pharma PLC patents

List of Benchmark Design Group patents

List of Seoul Semiconductor patents

List of Grifols patents

List of companies in defigen's investment portfolio

Companies in the Security industry

Patents where

Current Assignee

Name

is

Redx Pharma PLC

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11643408 N-pyridinyl acetamide derivatives as inhibitors of the WNT signaling pathway	Patent 11643408 was granted and assigned to Redx Pharma PLC on May, 2023 by the United States Patent and Trademark Office.	Redx Pharma PLC	Redx Pharma PLC		United States Patent and Trademark Office	11643408	May 9, 2023
	‌ US Patent 11459326 N-pyridinyl acetamide derivatives as Wnt signalling pathway inhibitors	Patent 11459326 was granted and assigned to Redx Pharma PLC on October, 2022 by the United States Patent and Trademark Office.	Redx Pharma PLC	Redx Pharma PLC		United States Patent and Trademark Office	11459326	October 4, 2022
	‌ US Patent 10183939 Fused bicyclic (hetero)aromatic compounds useful for the treatment of cancers	Patent 10183939 was granted and assigned to Redx Pharma PLC on January, 2019 by the United States Patent and Trademark Office.	Redx Pharma PLC	Redx Pharma PLC		United States Patent and Trademark Office	10183939	January 22, 2019
	‌ US Patent 11497751 Modulators of Rho-associated protein kinase	Patent 11497751 was granted and assigned to Redx Pharma PLC on November, 2022 by the United States Patent and Trademark Office.	Redx Pharma PLC	Redx Pharma PLC		United States Patent and Trademark Office	11497751	November 15, 2022
	‌ US Patent 10047079 N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathway	Patent 10047079 was granted and assigned to Redx Pharma PLC on August, 2018 by the United States Patent and Trademark Office.	Redx Pharma PLC	Redx Pharma PLC		United States Patent and Trademark Office	10047079	August 14, 2018
	‌ US Patent 10202375 N-pyridinyl acetamide derivatives as Wnt signalling pathway inhibitors	Patent 10202375 was granted and assigned to Redx Pharma PLC on February, 2019 by the United States Patent and Trademark Office.	Redx Pharma PLC	Redx Pharma PLC		United States Patent and Trademark Office	10202375	February 12, 2019
	‌ US Patent 10793560 N-pyridinyl acetamide derivatives as inhibitors of the WNT signaling pathway		Redx Pharma PLC	Redx Pharma PLC		United States Patent and Trademark Office	10793560	October 6, 2020
	‌ US Patent 10793562 N-pyridinyl acetamide derivatives as Wnt signalling pathway inhibitors	Patent 10793562 was granted and assigned to Redx Pharma PLC on October, 2020 by the United States Patent and Trademark Office.	Redx Pharma PLC	Redx Pharma PLC		United States Patent and Trademark Office	10793562	October 6, 2020
	‌ US Patent 8853429 Process and intermediate compounds useful in the preparation of statins	Patent 8853429 was granted and assigned to Redx Pharma PLC on October, 2014 by the United States Patent and Trademark Office.		Redx Pharma PLC		United States Patent and Trademark Office	8853429	October 7, 2014
	‌ US Patent 8278467 Process and intermediate compounds useful in the preparation of statins	Patent 8278467 was granted and assigned to Redx Pharma PLC on October, 2012 by the United States Patent and Trademark Office.		Redx Pharma PLC		United States Patent and Trademark Office	8278467	October 2, 2012
	‌ US Patent 11878020 Modulators of Rho-associated protein kinase	Patent 11878020 was granted and assigned to Redx Pharma PLC on January, 2024 by the United States Patent and Trademark Office.	Redx Pharma PLC	Redx Pharma PLC		United States Patent and Trademark Office	11878020	January 23, 2024

11 results

0 selected

11 results

0 selected